Compounds > hypericin

hypericin and mitoxantrone

hypericin has been researched along with mitoxantrone in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Briggs, JM; Bushman, FD; Carlson, HA; Jorgensen, WL; Lins, RD; Masukawa, KM; McCammon, JA; Rubins, K1
Lombardo, F; Obach, RS; Waters, NJ1
Adigbli, DK; Farooqui, N; Loizidou, M; Macrobert, AJ; Risley, P; Sousi, E; Taylor, I; Wilson, DG1
Fedoročko, P; Hiľovská, L; Jendželovská, Z; Jendželovský, R; Kovaľ, J; Mikeš, J1
Agostinis, P; de Witte, P; Elsen, S; Garg, AD; Krysko, DV; Vandenabeele, P1

Other Studies

5 other study(ies) available for hypericin and mitoxantrone

ArticleYear
Developing a dynamic pharmacophore model for HIV-1 integrase.
    Journal of medicinal chemistry, 2000, Jun-01, Volume: 43, Issue:11

    Topics: Computer Simulation; Drug Evaluation, Preclinical; HIV Integrase; HIV Integrase Inhibitors; Models, Chemical; Models, Molecular; Protein Conformation; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Photochemical internalisation of chemotherapy potentiates killing of multidrug-resistant breast and bladder cancer cells.
    British journal of cancer, 2007, Aug-20, Volume: 97, Issue:4

    Topics: Absorption; Anthracenes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Death; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mitoxantrone; Models, Biological; Perylene; Photochemotherapy; Tissue Distribution; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2007
Single pre-treatment with hypericin, a St. John's wort secondary metabolite, attenuates cisplatin- and mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells.
    Toxicology in vitro : an international journal published in association with BIBRA, 2014, Volume: 28, Issue:7

    Topics: Anthracenes; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Death; Cell Line, Tumor; Cisplatin; Drug Interactions; Humans; Hypericum; Mitoxantrone; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Perylene; RNA, Messenger

2014
Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
    Oncotarget, 2015, Sep-29, Volume: 6, Issue:29

    Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Calreticulin; Cancer Vaccines; Cell Death; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Humans; Immunotherapy; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mitoxantrone; Neoplasms; Ovarian Neoplasms; Perylene; Phagocytes; Phagocytosis; Phenotype; Photochemotherapy; Prognosis; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms

2015